<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02139969</url>
  </required_header>
  <id_info>
    <org_study_id>PE1401</org_study_id>
    <nct_id>NCT02139969</nct_id>
  </id_info>
  <brief_title>GreenLight XPS Laser System Retrospective Chart Review</brief_title>
  <official_title>GreenLight XPS Laser System for the Treatment of Benign Prostatic Hyperplasia: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Medical Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American Medical Systems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to gain information on the safety, efficacy, and quality of life
      in subjects who have had the GreenLight XPS procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective chart review conducted at six centers in the United States and
      Canada. This review will evaluate the safety and efficacy of GreenLight XPS in subjects who
      received treatment on or after 01-Aug-2010.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the proportion of patients who have mild or no BPH symptoms at 2-years post-procedure</measure>
    <time_frame>2-years post-procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate the occurrence of adverse events related to the study treatment.</measure>
    <time_frame>Up to 4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Summarize characteristics of the study procedure and immediate outcomes.</measure>
    <time_frame>Participants will be followed from admission through discharge from the medical facility, an expected average of 2 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess changes in quality of life related to BPH symptoms.</measure>
    <time_frame>Baseline through five years post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess changes in objective measures of urologic function.</measure>
    <time_frame>From baseline through five years post-procedure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize medical attention sought for treatment-related adverse events.</measure>
    <time_frame>Up to 90 days post-procedure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the frequency of treatment-related urinary incontinence.</measure>
    <time_frame>Up to 12 months post-procedure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the occurrence of surgical retreatment for BPH in GreenLight XPS patients.</measure>
    <time_frame>Procedure through five years post-procedure.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Benign Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>GreenLight XPS Laser System</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GreenLight XPS Laser System</intervention_name>
    <arm_group_label>GreenLight XPS Laser System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of males who have had the GreenLight XPS procedure with
        the MoXy fiber on or after 01-Aug-2010. The cohort will be selected from six pre-selected
        urology clinics in the US and one pre-selected urology clinic in Canada.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men who have had a GreenLight XPS procedure with a MoXy Fiber since 01-Aug-2010.

        Exclusion Criteria:

          -  Subject has had prior radiation.

          -  Subject has a diagnosis of neurogenic bladder confirmed by urodynamic studies (BOO,
             detrusor overactivity (DO), impaired detrusor contractor (IDC))

          -  Subject has a neurologic disorder that would impact bladder function (MS, Parkinson,
             Spinal Cord Injury) (note: Stroke patients not excluded)

          -  Subject has an artificial urinary sphincter
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmood A. Hai, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Affiliates Division, Comprehensive Urology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>El Camino Urology Medical Group, Inc.</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgia Urology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affiliates Division, Comprehensive Urology</name>
      <address>
        <city>Westland</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Metro Urology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Urology of Virginia, PLLC</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Montreal Hospital Center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2014</study_first_submitted>
  <study_first_submitted_qc>May 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2014</study_first_posted>
  <last_update_submitted>October 29, 2014</last_update_submitted>
  <last_update_submitted_qc>October 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>June 7, 2016</submitted>
    <returned>July 15, 2016</returned>
    <submitted>January 31, 2017</submitted>
    <returned>March 17, 2017</returned>
    <submitted>January 4, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

